Acne Medication Market Segmentation:
Product Segment Analysis
Antibiotics segment is projected to account for more than 46.5% acne medication market share by the end of 2035. According to NCBI, pharmacological drugs such as antibiotics are the first line of treatment for mild to moderate-stage acne. Antibiotics effectively kill skin bacteria and reduce inflammation surrounding the affected area and are available in two forms topical and oral, wherein clindamycin and erythromycin are widely adopted topical antibiotics, and tetracyclines and macrolide are oral ones. American Academy of Dermatology (AAD) estimates that the use of topical antibiotics alongside retinoids or benzoyl peroxide in acne treatment offers effective results.
Distribution Channel Segment Analysis
Sales of acne medications through retail and online pharmacies in acne medication market are anticipated to rise at a high CAGR throughout the forecast period. The easy availability of over-the-counter (OTC) medications is driving the online sales of acne drugs. Patients can easily compare and buy acne OTC medications without a prescription and a direct visit to physical stores, this convenience is contributing to their online sales growth. Retail pharmacies are also equipped with advanced and latest medications, which reduces the need to visit hospital pharmacies. Furthermore, online and retail pharmacies offer various discounts and offers, which make them the most sought-after mode of distribution channel.
Our in-depth analysis of the acne medication market includes the following segments:
|
Product |
|
|
Route of Administration |
|
|
Age Group |
|
|
Distribution Channel |
|
